A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus

Inclusion Criteria: * Male and female patients aged 19 - 70 years * Patients who have eczema or xerosis cutis at the area where investigational product is applied (arm or leg) * Patients whose result of the pruritus test (Visual Analogue Scale, VAS) at Visit 1 and 2 is 5 or more * Patients whose overall dry skin score of the area where investigational product is applied at Visit 1 and 2 is 2 points or more Exclusion Criteria: * Patients with pruritus caused by other medical, psychotic and nervous causes other than the skin disease * Patients with such skin diseases as malignant tumor or chronic urticaria among patients with skin diseases * Patients with simple pruritus caused by such allergic material as scabies, and insect bite wound * Patients with the symptom of systemic infection at the time of the participation in the clinical study * Patients with a history of taking topical treatment drug, topical steroid agent or antibiotics for the treatment of pruritus within 2 weeks * Patients with a history of taking oral steroid agent within 4 weeks * Patients with a history of taking a physical treatment for the treatment of pruritus including phototherapy within 4 weeks * Pregnant or breast-feeding women * Women at a childbearing age who has childbearing potential or has a plan to get pregnant during the clinical study period